Olink Holding AB likely has some euphoric investors following Thermo Fisher Scientific Inc.’s announcement of an agreement to acquire the proteomics company for $26 per share in cash. The price represents a premium of nearly 75% on its recent trading average and brings the deal’s value to a stunning $3.1 billion, with net cash of $143 million. Read More
Microsure BV recently secured €38 million (US$40 million) in a series B2 funding round that will allow it to finalize the development of its microsurgical robot, the Musa-3. The robot system is designed to give microsurgeons the precision, stability and control that are currently beyond human capabilities. “We want to make a super microsurgeon from every microsurgeon,” Sjaak Deckers, CEO of Microsure, told BioWorld.
“Digital therapeutics (DTx) for obesity may seem light years away,” Rhee Sang-youl, of Kyung Hee University Medical Center (KHMC), said to the Korea Society of Cardiology (KSC) 2023 audience members on October 13, “but the reality is that it’s right in front of us.” Read More
Wave Neuroscience Inc. is seeking patent protection for systems and methods for determining and optimizing the alpha burst parameters associated with a subject's brain. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aidoc, Aimil, Bayer, Cardio Diagnostics, Concertai, Evidation, Gleamer, Grail, Halo Precision Diagnostics, Odysight.ai, Oncotech, Optellum, Synerfuse, Terarecon. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Flobio, GE Healthcare, Werfen. Read More
